StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)

Close on Nov 17, 2026Market cap $4.48BP/E –Yield –

Ionis Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ionis Pharmaceuticals's price to book ratio was 10.7× on Nov 11, 2026, against 21.6× a year earlier. Over the last 5 years it ranged from 6.1× to 27.1×, with a median of 13.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.7×−10.0
2025Dec 31, 202520.6×+12.3
2024Dec 31, 20248.3×−14.7
2023Dec 29, 202323.0×+14.0
2022Dec 30, 20229.0×+0.9
2021Dec 31, 20218.1×+2.4
2020Dec 31, 20205.7×−0.6
2019Dec 31, 20196.4×−4.1
2018Dec 31, 201810.5×−9.9
2017Dec 29, 201720.4×−21.1
2016Dec 30, 201641.5×+11.2
2015Dec 31, 201530.3×+9.2
2014Dec 31, 201421.1×+9.6
2013Dec 31, 201311.5×+5.3
2012Dec 31, 20126.2×+2.4
2011Dec 30, 20113.8×−0.1
2010Dec 31, 20104.0×–

More Ionis Pharmaceuticals figures

See a number that looks wrong?